New Zealand Markets close in 6 hrs 11 mins

Stocks to watch

Stocks of interest at the close of trading on Friday, February 14.

-

NOX - NOXOPHARM - up 1.5 cents, or 6.7 per cent, to 24 cents

The Sydney biotech says a clinical trial suggests its radiation-sensitising suppository was able to extend the average lifespan of 32 men with terminal prostate cancer.

The men were treated with Veyonda in combination with Novartis' $6 billion experimental radioactive drug 177Lu-PSMA-617 at St Vincent's Hospital Sydney after at least two and in most cases three lines of therapy had failed.

They lived an average of 17.1 months despite two-thirds of them having over 20 tumours in their bones and lymph nodes.

BBN - BABY BUNTING - down 20 cents, or 5.3 per cent, to $3.60

The specialist baby goods retailer increased statutory profit by 0.6 per cent to $4.838 million in the six months to December 29, while revenue increased by 5.0 per cent to $186.39 million.

The board announced an interim fully franked dividend of 4.1 cents per share, up from 3.3 cents last year.

FAR - FAR LIMITED - down 0.3 cents, or 8.8 per cent, to 3.1 cents

WPL - WOODSIDE PETROLEUM - down 91 cents, or 2.7 per cent, to $32.83

The International Court of Arbitration of the International Chamber of Commerce has ruled in favour of Woodside and against FAR in relation to a long-running dispute over a stake in a $6 billion oil field in Senegal.

ConocoPhillips sold its stake in the Sangomar project to Woodside in 2016 for $US430 million; FAR, which also holds a stake in the project, argued it should have had a chance to pre-empt the sale.